Marimed (MRMD) Long-Term Deferred Tax (2019 - 2020)
Marimed (MRMD) reported Long-Term Deferred Tax of $57.9 million for Q4 2020, down 16.02% year-over-year from $68.9 million in Q1 2020, and down 16.02% quarter-over-quarter from $68.9 million in Q4 2019.
Marimed (MRMD) Long-Term Deferred Tax (2019 - 2020) Analysis & Trends
Marimed (MRMD) has 2 years of Long-Term Deferred Tax data on file, last reported at $57.9 million in Q4 2020.
- Long-Term Deferred Tax for Q4 2020 came in at $57.9 million, down 16.02% year-over-year; the trailing twelve-month figure through Dec 2020 was $57.9 million (down 16.02% YoY), and the FY2020 annual result was $57.9 million, down 16.02% from the prior year.
- Long-Term Deferred Tax retreated to $57.9 million in Q4 2020 per MRMD's latest filing, from $68.9 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $68.9 million in Q4 2019 and troughed at $57.9 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Marimed | - | - | 15.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 57.85 Mn |
| Dec 31, 2019 | 68.89 Mn |